Telerehabilitation for TMD

Sponsor
University of Minnesota (Other)
Overall Status
Recruiting
CT.gov ID
NCT05318313
Collaborator
(none)
189
1
23.6
8

Study Details

Study Description

Brief Summary

This study will compare after physical therapy for Temporomandibular Disorders (TMD) performed either in-person or virtually using telerehabilitation. Comparing diagnostic reliability and quality-of-life outcomes in each group will determine (based on a 10% margin) whether delivering physical therapy via telerehabilitation is as good as standard in-person care for these individuals. Long term outcomes including patient satisfaction, cost-effectiveness analysis, and functional status will describe the feasibility of telerehabilitation as a management intervention for this population.

Study Design

Study Type:
Observational
Anticipated Enrollment :
189 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Telerehabilitation Effectiveness for Individuals With Temporomandibular Disorders (TMD): A Non-Inferiority Study
Actual Study Start Date :
Jun 15, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Telerehabilitation only

Participants choose to have all of their physical therapy provided virtually throughout the length of the study

Other: Telerehabilitation
The TR PT evaluation and follow-up visits will be performed via Zoom software

In-person only

Participants choose to have all of their physical therapy provided in-person throughout the length of the study

Hybrid 1

The TR PT evaluation and follow-up visits in the initial 6 weeks will be performed via Zoom software and subsequent follow-up visits will switch to in person after 6 weeks

Other: Telerehabilitation
The TR PT evaluation and follow-up visits will be performed via Zoom software

Hybrid 2

The PT evaluation and follow-up visits in the initial 6 weeks will be performed in person and will switch to TR via Zoom software after 6 weeks

Other: Telerehabilitation
The TR PT evaluation and follow-up visits will be performed via Zoom software

Outcome Measures

Primary Outcome Measures

  1. Specialist diagnosis [Measured directly after the PT evaluation (Day 1)]

    Diagnosis will be determined by putting clinical assessment results into the Brief Diagnostic Criteria for TMD (Brief DC/TMD) algorithm and getting one or more of 7 possible diagnoses: TMJ arthralgia (joint), Masticatory myofascial pain (muscle), TMJ disc displacement with reduction (joint), TMJ disc displacement without reduction (joint), TMJ arthritis (joint), TMD headache (muscle), other (neither). The diagnosis will be measured as one of four options: 1. joint; 2. muscle; 3. both; or 4. neither.

  2. Diagnostic agreement [Measured directly after the PT evaluation (Day 1)]

    Agreement data for each subject will be collected comparing two specialist diagnoses: dentist and physical therapist. Agreement about the diagnostic category will be recorded as a binary "yes/no" measure.

  3. The Oral Health Impact Profile for TMD summary score [6 weeks after intervention onset]

    The OHIP-TMD is a condition-specific quality-of-life scale with 22 items and a 0-4 scoring option for each item. A higher score means lower quality-of life. The summary score after 6 weeks will be compared to the baseline summary score, and a score decrease ≥6.9 units will be considered evidence of therapy success. The proportion of therapy success in each group will be used for non-inferiority comparison.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18-70 years old

  • Referred to PT with ≥1 TMD subtype diagnosis

  • PI has no previous knowledge of the participant's diagnosis

  • Email access

  • Possession of any device that can be positioned for hands-free TR visits (TR group only)

  • Willingness and ability to comply with all study requirements and PT program

  • Able to provide informed consent

Exclusion Criteria:
  • Non-English speakers

  • Permanent residence outside of the state of Minnesota (TR group only)

  • Women in the last trimester of pregnancy

  • Referred for post-surgical rehabilitation

  • Severe chronic pain as identified by level 4 classification on the GCPS

  • Current diagnosis or existence of the following conditions that can limit response to

PT and participation in study activities:
  1. Neuropathic pain

  2. Fibromyalgia and/or generalized widespread pain on both sides of the body in ≥3 areas above and below the waist

  3. Rheumatoid arthritis or juvenile idiopathic arthritis

  4. Dystonia or other movement disorder

  5. Fractures and/or recent jaw or facial trauma

  6. Malignancies

  7. Current substance abuse

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Minnesota Minneapolis Minnesota United States 55455

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: Emily Kahnert, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT05318313
Other Study ID Numbers:
  • DENT-2022-30141
First Posted:
Apr 8, 2022
Last Update Posted:
Jun 22, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Minnesota
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2022